The value of extended surgery for pancreatic cancer in the context of neoadjuvant therapy
10.3760/cma.j.cn112139-20200422-00323
- VernacularTitle:新辅助治疗背景下胰腺癌扩大切除术的应用价值
- Author:
Taiping ZHANG
1
;
Yueze LIU
;
Zhe CAO
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院基本外科 100730
- Keywords:
Pancreatic neoplasms;
Surgical procedures, operative;
Extended surgery;
Neoadjuvant therapy
- From:
Chinese Journal of Surgery
2020;58(7):481-485
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer has a high degree of malignancy and a poor prognosis, and the treatment effect is still not ideal. For patients with advanced pancreatic cancer, extended surgery for pancreatic cancer alone cannot benefit the patients. However, with the development of neoadjuvant therapy in the field of pancreatic cancer, some cases have obtained radical operation. Studies have shown that neoadjuvant therapy, combined with extended surgery for pancreatic cancer, can improve the overall prognosis of patients, indicating that surgical techniques themselves are still useful. In this article, combined with the relevant guidelines and clinical research progress of pancreatic cancer, the controversy and progress of the extended surgery for pancreatic cancer in the context of neoadjuvant therapy is summarized, and the resectability and prognosis evaluation index after neoadjuvant therapy is discussed, in order to standardize the treatment of pancreatic cancer, enhance the understanding of extended surgery for pancreatic cancer, and further improve the prognosis of pancreatic cancer.
